We specialize in developing mono- and multi-antigenic subunit vaccines for animal health. Our proprietary antigen design technique combines multiple epitopes to enhance immunogenicity while maintaining high yields during manufacturing, resulting in cost-effective vaccine production at scale.
Headquarters:
Chile
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2017 (8 years)
Address:
LA CAPITANÍA 80; LAS CONDES, SANTIAGO METROPOLITAN REGION, CL
LOW
spending power
